GLOBAL INDEMNITY GROUP LLC-A (GBLI)

US37959R1032 - Common Stock

32.31  +0.32 (+1%)

Fundamental Rating

4

GBLI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. The financial health of GBLI is average, but there are quite some concerns on its profitability. GBLI has a correct valuation and a medium growth rate. GBLI also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

In the past year GBLI was profitable.
GBLI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: GBLI reported negative net income in multiple years.
Each year in the past 5 years GBLI had a positive operating cash flow.

1.2 Ratios

GBLI has a Return On Assets (1.44%) which is in line with its industry peers.
The Return On Equity of GBLI (3.85%) is worse than 63.57% of its industry peers.
GBLI has a Return On Invested Capital of 1.52%. This is comparable to the rest of the industry: GBLI outperforms 54.29% of its industry peers.
GBLI had an Average Return On Invested Capital over the past 3 years of 1.76%. This is below the industry average of 4.07%.
Industry RankSector Rank
ROA 1.44%
ROE 3.85%
ROIC 1.52%
ROA(3y)0.94%
ROA(5y)1.01%
ROE(3y)2.58%
ROE(5y)2.88%
ROIC(3y)1.76%
ROIC(5y)N/A

1.3 Margins

GBLI's Profit Margin of 4.73% is in line compared to the rest of the industry. GBLI outperforms 41.43% of its industry peers.
GBLI has a Operating Margin (6.25%) which is comparable to the rest of the industry.
Industry RankSector Rank
OM 6.25%
PM (TTM) 4.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBLI is destroying value.
GBLI has less shares outstanding than it did 1 year ago.
GBLI has less shares outstanding than it did 5 years ago.
GBLI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

GBLI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.16
WACC9.22%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

GBLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.54%, which is quite impressive.
The Earnings Per Share has been growing by 15.95% on average over the past years. This is quite good.
The Revenue for GBLI has decreased by -15.98% in the past year. This is quite bad
GBLI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.12% yearly.
EPS 1Y (TTM)51.54%
EPS 3Y47.01%
EPS 5Y15.95%
EPS growth Q2Q172.34%
Revenue 1Y (TTM)-15.98%
Revenue growth 3Y-3.31%
Revenue growth 5Y1.12%
Revenue growth Q2Q-29.78%

3.2 Future

The Earnings Per Share is expected to grow by 32.39% on average over the next years. This is a very strong growth
Based on estimates for the next years, GBLI will show a decrease in Revenue. The Revenue will decrease by -4.02% on average per year.
EPS Next Y27.63%
EPS Next 2Y32.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.29%
Revenue Next 2Y-4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.40, the valuation of GBLI can be described as correct.
GBLI's Price/Earnings is on the same level as the industry average.
GBLI is valuated rather cheaply when we compare the Price/Earnings ratio to 28.28, which is the current average of the S&P500 Index.
GBLI is valuated correctly with a Price/Forward Earnings ratio of 12.85.
GBLI's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.88. GBLI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.4
Fwd PE 12.85

4.2 Price Multiples

61.43% of the companies in the same industry are more expensive than GBLI, based on the Enterprise Value to EBITDA ratio.
GBLI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 10.22
EV/EBITDA 10.22

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GBLI's earnings are expected to grow with 32.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.59
PEG (5Y)1.03
EPS Next 2Y32.39%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

GBLI has a Yearly Dividend Yield of 4.39%, which is a nice return.
GBLI's Dividend Yield is rather good when compared to the industry average which is at 4.26. GBLI pays more dividend than 82.86% of the companies in the same industry.
GBLI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.39%

5.2 History

The dividend of GBLI has a limited annual growth rate of 1.64%.
GBLI has been paying a dividend for over 5 years, so it has already some track record.
As GBLI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)1.64%
Div Incr Years0
Div Non Decr Years5

5.3 Sustainability

GBLI pays out 58.80% of its income as dividend. This is a bit on the high side, but may be sustainable.
GBLI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.8%
EPS Next 2Y32.39%
EPS Next 3YN/A

GLOBAL INDEMNITY GROUP LLC-A

NYSE:GBLI (5/3/2024, 7:04:01 PM)

32.31

+0.32 (+1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap438.45M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 4.39%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.4
Fwd PE 12.85
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.59
PEG (5Y)1.03
Profitability
Industry RankSector Rank
ROA 1.44%
ROE 3.85%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.25%
PM (TTM) 4.73%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)51.54%
EPS 3Y47.01%
EPS 5Y
EPS growth Q2Q
EPS Next Y27.63%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.98%
Revenue growth 3Y-3.31%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y